EU Certifies Vetter’s Supply Chain is Better

Dec 08, 2015

pharmamanufacturing.com staff

Vetter, well-known CMO and experienced aseptic parenteral processor, recently achieved Authorized Economic Operator Full (AEO-F) status from the European Union. Internationally accepted, AEO-F certification affirms that Vetter maintains the highest reliability, solvency and safety standards in international pharmaceutical trade. The AEO-F certificate is currently accepted by the U.S. and Japan, the EU Member States, Switzerland, Norway and China.

According to Vetter, the certification facilitates the import of drugs in third countries and confirms the quality, reliability and performance of its entire supply chain. Equipped with the AEO-F, customs procedures associated with consignments will be simplified and accelerated, “all of which results in shortened transport durations, as well as improved fulfillment of pharmaceutical requirements for transit times,” says the company’s press release. Another advantage, said Vetter, is how it accelerates regulatory proceedings for security reviews and audits.

"With the recognition afforded by the granting of the AEO-F certificate, we can enable our customers not only a fast and smooth international customs clearance, but more importantly, a very high standard of safety,” explained Vetter Supply Chain Management SVP Carsten Press. “The certification is important for Vetter, and at the same time, it is also further evidence of the high service and product quality we offer to our customers.” 

Show Comments
Hide Comments

Join the discussion

We welcome your thoughtful comments.
All comments will display your user name.

Want to participate in the discussion?

Register for free

Log in for complete access.

Comments

No one has commented on this page yet.

RSS feed for comments on this page | RSS feed for all comments